Measuring the COVID-19 Mortality Burden in the United States A Microsimulation Study

被引:11
|
作者
Reif, Julian [1 ,2 ,4 ]
Heun-Johnson, Hanke [3 ,5 ]
Tysinger, Bryan [3 ,5 ]
Lakdawalla, Darius [2 ,3 ,5 ]
机构
[1] Univ Illinois, Champaign, IL USA
[2] Natl Bur Econ Res, Cambridge, MA 02138 USA
[3] Univ Southern Calif, Los Angeles, CA 90007 USA
[4] Univ Illinois, Gies Coll Business, Dept Finance, 515 East Gregory St, Champaign, IL 61820 USA
[5] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, 635 Downey Way,VPD 312,VPD 514K,VPD 414K, Los Angeles, CA 90089 USA
关键词
CONSEQUENCES; BENEFITS; OBESITY; RISK;
D O I
10.7326/M21-2239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fully assessing the mortality burden of the COVID-19 pandemic requires measuring years of life lost (YLLs) and accounting for quality-of-life differences. Objective: To measure YLLs and quality-adjusted life-years (QALYs) lost from the COVID-19 pandemic, by age, sex, race/ethnicity, and comorbidity. Design: State-transition microsimulation model. Data Sources: Health and Retirement Study, Panel Study of Income Dynamics, data on excess deaths from the Centers for Disease Control and Prevention, and nursing home death counts from the Centers for Medicare & Medicaid Services. Target Population: U.S. population aged 25 years and older. Time Horizon: Lifetime. Perspective: Individual. Intervention: COVID-19 pandemic through 13 March 2021. Outcome Measures: YLLs and QALYs lost per 10 000 persons in the population. The estimates account for the age, sex, and race/ethnicity of decedents, along with obesity, smoking behavior, lung disease, heart disease, diabetes, cancer, stroke, hypertension, dementia, and nursing home residence. Results of Base-Case Analysis: The COVID-19 pandemic resulted in 6.62 million QALYs lost (9.08 million YLLs) through 13 March 2021, with 3.6 million (54%) lost by those aged 25 to 64 years. The greatest toll was on Black and Hispanic communities, especially among men aged 65 years or older, who lost 1138 and 1371 QALYs, respectively, per 10 000 persons. Absent the pandemic, 38% of decedents would have had average or above-average life expectancies for their subgroup defined by age, sex, and race/ethnicity. Results of Sensitivity Analysis: Accounting for uncertainty in risk factors for death from COVID-19 yielded similar results. Limitation: Estimates may vary depending on assumptions about mortality and quality-of-life projections. Conclusion: Beyond excess deaths alone, the COVID-19 pandemic imposed a greater life expectancy burden on persons aged 25 to 64 years, including those with average or above-average life expectancies, and a disproportionate burden on Black and Hispanic communities.
引用
收藏
页码:1700 / +
页数:11
相关论文
共 50 条
  • [31] Health outcomes and economic burden of hospitalized COVID-19 patients in the United States
    Di Fusco, Manuela
    Shea, Kimberly M.
    Lin, Jay
    Nguyen, Jennifer L.
    Angulo, Frederick J.
    Benigno, Michael
    Malhotra, Deepa
    Emir, Birol
    Sung, Anita H.
    Hammond, Jennifer L.
    Stoychev, Sophia
    Charos, Apostolos
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 308 - 317
  • [32] Publisher Correction: Burden and characteristics of COVID-19 in the United States during 2020
    Sen Pei
    Teresa K. Yamana
    Sasikiran Kandula
    Marta Galanti
    Jeffrey Shaman
    Nature, 2022, 601 : E6 - E6
  • [33] Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic
    Roth, Gregory A.
    Emmons-Bell, Sophia
    Alger, Heather M.
    Bradley, Steven M.
    Das, Sandeep R.
    de Lemos, James A.
    Gakidou, Emmanuela
    Elkind, Mitchell S. V.
    Hay, Simon
    Hall, Jennifer L.
    Johnson, Catherine O.
    Morrow, David A.
    Rodriguez, Fatima
    Rutan, Christine
    Shakil, Saate
    Sorensen, Reed
    Stevens, Laura
    Wang, Tracy Y.
    Walchok, Jason
    Williams, Joseph
    Murray, Christopher
    JAMA NETWORK OPEN, 2021, 4 (05) : E218828
  • [34] Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: A retrospective study
    Merugu, Ganesh Prasadd
    Neishwat, Zeid
    Balla, Mamtha
    Patel, Mitra
    Fatima, Rawish
    Sheikh, Taha
    Kotturi, Vinay
    Bommana, Venugopala
    Pulagam, Gautham
    Kaminski, Brian
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2875 - 2882
  • [35] Exacerbation of COVID-19 mortality by the fragmented United States healthcare system: A retrospective observational study
    Campbell, Travis
    Galvani, Alison P.
    Friedman, Gerald
    Fitzpatrick, Meagan C.
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 12
  • [36] Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study
    Ahlers, Michael
    Aralis, Hilary
    Tang, Wilson
    Sussman, Jeremy B.
    Fonarow, Gregg C.
    Ziaeian, Boback
    BMJ MEDICINE, 2022, 1 (01):
  • [37] A longitudinal study of COVID-19 disclosure stigma and COVID-19 testing hesitancy in the United States
    Dayton, L.
    Song, W.
    Kaloustian, I.
    Eschliman, E. L.
    Strickland, J. C.
    Latkin, C.
    PUBLIC HEALTH, 2022, 212 : 14 - 21
  • [38] COVID-19 pandemic in the United States
    Bergquist, Savannah
    Otten, Thomas
    Sarich, Nick
    HEALTH POLICY AND TECHNOLOGY, 2020, 9 (04) : 623 - 638
  • [39] COVID-19 and Leisure in the United States
    Anderson, Stephen
    WORLD LEISURE JOURNAL, 2020, 62 (04) : 352 - 356
  • [40] COVID-19 and cancer in the United States
    Grob, Sydney
    Mucci, Lorelei A.
    EPIDEMIOLOGIA & PREVENZIONE, 2020, 44 (5-6): : 26 - 27